94864 ⎘
Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Piperidine and piperazine derivatives
#302Selective estrogen receptor modulators for the treatment of vasomotor symptoms
#303NON-IMIDAZOLE ALKYLAMINES AS HISTAMINE H3-RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS
#304PIPERAZINE DERIVATIVES AND THEIR USE AS LEPTIN RECEPTOR MODULATORS
#305Prodrugs containing novel bio-cleavable linkers
#306Prodrugs containing novel bio-cleavable linkers
#307Prodrugs containing novel bio-cleavable linkers
#308High penetration compositions and their applications
#309Nitric Oxide Releasing Prodrugs of Therapeutic Agents
#310NOVEL PROCESS FOR PREPARING HIGHLY PURE LEVOCETIRIZINE AND SALTS THEREOF
#311Plating bath and method
#312Substituted cyclopentanes or cyclopentanones as therapeutic agents
#313Processes for the synthesis of levocetirizine and intermediates for use therein
#3141-butyl-2-hydroxyaralkyl piperazine derivatives and the uses as anti-depression medicine thereof
#315Tetrahydro-naphthalene derivatives
#316NOVEL WATER BASED PROCESS FOR THE PREPARATION OF SUBSTITUTED DIPHENYLMETHYL PIPERAZINES
#317Salt and photoresist composition containing the same
#318THIOTUNGSTATE ANALOGUES AND USES THEREOF
#319Biological buffers with wide buffering ranges
#320Catalyst and process for preparing an amine
#321Cyclohexane derivatives and uses thereof
#322Anesthetic Compounds
#323Phenyl piperazine compounds, pharmaceutical composition including the same and use thereof
#324Therapeutic cyclopentane derivatives
#325THERAPEUTIC AGENT FOR CANCER RESISTANT TO PROTEASE INHIBITOR
#326Vinyl ether compounds and methods of their preparation and use
#327Bicyclic-substituted amines as histamine-3 receptor ligands
#328Process for the preparation of delmopinol and derivatives thereof
#3291-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and P40
#330COMPOUNDS
#331SUBSTITUTED PHENYLAMINO-BENZENE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH MITOGEN EXTRACELLULAR KINASE ACTIVITY
#332Cationic alcohols and uses thereof
#333QUINOLINE, NAPHTHALENE AND CONFORMATIONALLY CONSTRAINED QUINOLINE OR NAPHTHALENE DERIVATIVES AS ANTI-MYCOBACTERIAL AGENTS
#334Therapeutic compounds
#335Reactive ionic liquids
#336N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase
#337Inhibitors for the soluble epoxide hydrolase
#338NOVEL ANALOGS OF CHOLINE FOR NEUROPROTECTION AND COGNITIVE ENHANCEMENT IN NEURODEGENERATIVE DISORDERS
#339NOVEL AMINODICARBOXYLIC ACID DERIVATIVES HAVING PHARMACEUTICAL PROPERTIES
#340Estrogen Agonists/Antagonists For Preventing Breast Cancer
#341Cyclic hydrocarbon compounds for the treatment of diseases
#3421,4-disubstituted naphthalenes as inhibitors of p38 map kinase
#343Aryl potassium channel blockers and uses thereof
#344SUBSTITUTED ARYL ALKYLAMINO-OXY-ANALOGS AND USES THEREOF
#345VIRAL POLYMERASE INHIBITORS
#346ANALGESIC THAT BINDS FILAMIN A
#347ALPHA-KETOAMIDES AND DERIVATIVES THEREOF
#348Novel Compounds and Methods of Using Them
#349METHOD OF ENHANCING CELLULAR PRODUCTION OF MOLECULAR CHAPERONE, HYDROXYLAMINE DERIVATIVES USEFUL FOR ENHANCING THE CHAPERONE PRODUCTION AND THE PREPARATION THEREOF
#350METHOD FOR THE PREPARATION OF LASOFOXIFENE
#351Cell differentiation inducer
#352Piperidine and piperazine derivatives
#353Stereoselective Alkylation of Chiral 2-Methly-4 Protected Piperazines
#354Dihydronaphthalene compound and use thereof
#355Functionalized ionic liquids, and methods of use thereof
#356Process for the preparation of delmopinol and derivatives thereof
#357Arylsulfonamide derivatives for use as CCR3 antagonists in the treatment of inflammatory and immunological disorders
#358Biological buffers with wide buffering ranges
#359Methods and Compositions for Treating Amyloid-Related Diseases
#360Benzophenone hybrids as anticancer agents and processes for the preparation thereof
#361Pro-drugs of NSAIAS with very high skin and membranes penetration rates and their new medicinal uses
#362METHODS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF HEXAHYDROFURO [2,3-B]FURAN-3-OL
#363STEREOSELECTIVE HYDROGENATION PROCESS FOR PREPARING CIS-6-PHENYL-5-[4-(2-PYRROLIDIN-1-YL-ETHOXY)-PHENYL]-2-METHOXY-5,6,7,8-TETRAHYDRONAPHTHALENE HYDROCHLORIDE
#364Functionalized Ionic Liquids, and Methods of Use Thereof
#365Oligomer-Antihistamine Conjugates
#366Therapeutic compounds
#367Methods and compositions for treating amyloid-related diseases
#368Process for the preparation of levocetirizine and intermediates thereof
#369C7-fluoro substituted tetracycline compounds
#370CATIONIC LIPIDS AND USES THEREOF
#371Biological buffers with wide buffering ranges
#372Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders
#3732,5-linked polyfluorenes for optoelectronic devices
#374Cytokine inhibitors
#375Cytokine inhibitors
#376Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors
#377SUBSTITUTED PIPERAZINES, (1,4) DIAZEPINES, AND 2,5-DIAZABICYCLO (2.2.1) HEPTANES AS HISTAMINE H1 AND/OR H3 ANTAGONISTS OR HISTAMINE H3 REVERSE ANTAGONISTS
#378CATIONIC LIPIDS AND USES THEREOF
#379N-(3-AMINO-2-HYDROXY-PROPYL) SUBSTITUTED ALKYLAMIDE COMPOUNDS
#380Rho kinase inhibitors
#381Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
#382NON-IMIDAZOLE ARYLOXYALKYLAMINES
#383Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
#384Selective estrogen receptor modulator
#385Tetra-O-substituted butane-bridge modified NDGA derivatives, their synthesis and pharmaceutical use
#386Phenyl piperazine compounds, pharmaceutical composition comprising the same, and use thereof
#387Phenyl piperazine compounds, pharmaceutical composition including the same and use thereof
#388CATIONIC LIPIDS AND USES THEREOF
#389Therapeutic compounds
#390Therapeutic compounds
#391Therapeutic compounds
#392Biological buffers with wide buffering ranges
#393Biological buffers with wide buffering ranges
#394Novel Aryl- and Heteroarylpiperazines
#395Compounds that stimulate glucose utilization and methods of use
#396NMDA receptor antagonists for neuroprotection
#397PHARMACEUTICALLY EFFECTIVE COMPOUNDS
#398Hsp90 family protein inhibitors
#399Therapeutic compounds
#400THERAPEUTIC CYCLOPENTANE DERIVATIVES
#401Npy antagonists, preparation and uses
#4022-adamantylurea derivatives as selective 11beta-HSD1 inhibitors
#403CXCR2 inhibitors
#404Piperazine Derivatives
#405Intermediates useful for the preparation of aripiprazole and methods for the preparation of the novel intermediates and aripiprazole
#406Aminodicarboxylic acid derivatives having pharmaceutical properties
#407Ionic Liquids Containing a Sulfonate Anion
#408INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME
#409Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process
#410Inhibitors of histone deacetylase
#411Pharmaceutical compounds
#412Compositions and methods for modulating a kinase cascade
#413TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS
#414Process for the preparation of delmopinol and derivatives thereof
#415Stabilized protease composition
#416Sulphones which modulate the action of gamma secretase
#417Histone deacetylase inhibitors
#418Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders
#419Histamine H3-receptor ligands and their therapeutic applications
#420Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
#4211-PHENYLALCOXY-2-BETA-PHENYLETHYL DERIVATIVES AS P-GLYCOPROTEIN (P-GP) INHIBITORS USEFUL IN DRUG RESISTANCE EVENTS
#422Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
#423DEUTERIUM-ENRICHED LEVOCEDTIRIZINE
#424Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
#425Carboxamidine derivatives and their use in the treatment of vascular diseases
#426DEUTERIUM-ENRICHED LASOFOXIFENE
#427Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
#428DEUTERIUM-ENRICHED CETIRIZINE
#429Antithrombotic diamides
#430Bicyclic-substituted amines as histamine-3 receptor ligands
#431ANTITUMOR AGENT
#432Process for obtaining cetirizine dihydrochloride
#433Vasopressin Vantagonists
#434Selective Estrogen Receptor Modulators for the Treatment of Vasomotor Symptoms
#435SOLUBLE EPOXIDE HYDROLASE INHIBITORS
#436Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
#437PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL INTERMEDIATE
#438HETEROCYCLIC COMPOUNDS
#439Antiparasitic Compounds
#440Thiourea derivatives
#441NON-IMIDAZOLE ARYLOXYALKYLAMINES
#442Triphenylethylene Compounds Useful as Selective Estrogen Modulators
#443Muscarinic Receptor Antagonists
#444Tetrahydro-naphthalene derivatives
#445Pyroglutamate salts and their use in the optical resolution of intermediates for the synthesis of dextrocetirizine and levocetirizine
#446Melanocortin-4 receptor binding compounds and methods of use thereof
#447Stilbene derivatives as new cancer therapeutic agents
#448Benzonitryl and nitrobenzyl derivatives that modulate androgen receptors
#449Triphenylethylene Compounds Useful as Selective Estrogen Receptor Modulators
#450N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof
#451Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
#4522-(Arylalkoxy)-1-Phenylethylamine Derivatives As NK1 Antagonist And Serotonin Reuptake Inhibitors
#453Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy] propyl] -piperidine
#454Calcium receptor modulating agents
#455Selective estrogen receptor modulators containing a phenylsulfonyl group
#456PYRIMIDINE-2,4-DIAMINE DERIVATIVES AND THEIR USE AS JAK2 KINASE INHIBITORS
#457PROCESSES FOR THE PREPARATION OF AMINOETHOXYBENZYL ALCOHOLS
#458SOLUBLE EPOXIDE HYDROLASE INHIBITORS
#459Crystalline Non-Solvated Methanesulfonic Acid Salt of 1-(4-(2-Piperidinylethoxy)Phenoxy)-2-(3-Hydroxyphenyl)-6-Hydroxynaphthalene
#460Cinnamic, phenylpropiolic and phenylpropanoic acid derivatives useful as anti-tumor agents
#461Lithium Salts of Pyrroldinium Type Zwitterion and the Preparation Method of the Same
#462Cell differentiation inducer
#463Histamine H-receptor ligands and their therapeutic application
#464Process for the preparation of 2- (2- (4- (bis (4-flourophenyl) methyl) -pipe razin-1-yl) ethoxy acetic acid derivatives or corresponding salt forms thereof and intermediates therefor
#465Receptor function regulating agent
#466Ctgf Expression Inhibitor
#467Prostaglandin prodrugs
#468Substituted aryl cycloalkanoyl derivatives and methods of their use
#469Serotonin reuptake inhibitors
#470Functionalized ionic liquids, and methods of use thereof
#471Nitrogen-containing organic compound, resist composition and patterning process
#472Adamantyl acetamides as 11-β hydroxysteroid dehydrogenase inhibitors
#473Rapidly Disintegrating Taste Masked Compositions and a Process for Its Preparations
#474Phenoxymethylalkyne inhibitors of LTA4H for treating inflammation
#475Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
#476Pharmaceutically effective compounds
#477Dicarboxylic acid derivatives with pharmaceutical properties
#478Substituted phenoxy-and phenylthio-derivatives for treating proliferative disorders
#4791,4-disubstituted naphthalenes as inhibitors of P38 MAP kinase
#480DIPEPTIDE NITRILES
#481Methods and compositions for treating amyloid-related diseases
#482Novel Heterocyclic Compounds
#483Naphthaline derivatives as H3 inverse agonists
#484Mercaptophenyl naphthyl methane compounds and synthesis thereof
#485Method for the continuous production of an amine
#486Indene derivatives and process for the preparation thereof
#487Biaromatic compound activators of PPARγ receptors and cosmetic/pharmaceutical compositions comprised thereof
#488Sulphones which modulate the action of gamma-secretase
#489Cyclic amine derivative or salt thereof
#490Pharmaceutical compounds
#4912-(arylalkoxy)-1-phenylethylamine derivatives as NKantagonist and serotonin reuptake inhibitors
#492Indene derivatives and process for the preparation thereof
#4933-(4-benzyloxyphenyl) propanoic acid derivatives
#494Enantjomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
#495CYCLOHEXYL DERIVATIVES AS SELECTIVE ESTROGEN RECEPTOR MODULATORS
#496Polypharmacophoric agents
#497Biphenyl carboxylic amide p38 kinase inhibitors
#4981,2-di(cyclic)substituted benzene compounds
#499Selective estrogen receptor modulators
#500Amphiphilic pyridinium compounds, method of making and use thereof
#5014-phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (MEK) inhibitors
#502Composition and synthesis of new reagents for inhibition of HIV replication
#503Ionic liquid, method for producing same, double layer capacitor comprising same, and lithium battery
#504Selective estrogen receptor modulators
#505Methods and compositions for mitigating pain
#506NOVEL SUBSTITUTED DIAMINE DERIVATIVES USEFUL AS MOTILIN AGONISTS
#507Azinone and diazinone V3 inhibitors for depression and stress disorders
#508Hsp90 family protein inhibitors
#509Ionic liquids, electrolyte salts for electrical storage devices, liquid electrolytes for electrical storage devices, electrical double-layer capacitors, and secondary batteries
#510Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
#511Methods and compositions for treating amyloid-related diseases
#512Aminoalkyl substituted esters and amides of fumaric acid for neutralizing malodor
#513Pharmaceutical for treatment of neurological and neuropsychiatric disorders
#514Aryl and heteroaryl compounds and methods to modulate coagulation
#5151,2-di(cyclic) substituted benzene compounds
#516Inhibitors for the soluble epoxide hydrolase
#5172-[2-[4-[(4-chlorophenyl) phenylmethyl]-1-piperazinyl]ethoxy]acetic acid monohydrochloride as anti-allergenic compound and process for its production
#518Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl]piperazine
#519Modulators of the glucocorticoid receptor
#520Non-imidazole alkylamines as histamine H- receptor ligands and their therapeutic applications
#521Dipeptide nitriles
#522Diamino-functional chalcones
#523Non-imidazole aryloxyalkylamines
#524Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
#525Enantiomers of 1-[(4-chlorophenyl) phenylmethyl)-4-[(4-methylphenyl)sulfonyl] piperazine
#526Methods and compositions for treating amyloid-related diseases
#527Phenyl and pyridyl LTA4H modulators
#528Prodrugs containing novel bio-cleavable linkers
#5293-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
#530N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds
#531Bicyclic-substituted amines as histamine-3 receptor ligands
#532Substituted diamine derivatives useful as motilin antagonists
#533Selective estrogen receptor modulators containing a phenylsulfonyl group
#534Crystalline non-solvated 1-(4-(2-piperidinylethoxy)phenoxy)-2-(4-methanesulfonylphenyl)-6-hydroxynaphthalene hydrochloride
#535Quaternary ammonium salts
#536Thiotungstate analogues and uses thereof
#537Processes for the preparation of aminoethoxybenzyl alcohols
#538Dihydro-dibenzo[B,E]oxepine based selective estrogen receptor modulators, compositions and methods
#539Tetrahydro-naphthalene derivatives
#540Derivative of dihydro-dibenzo (a) anthracenes and their use as selective estrogen receptor modulators
#541Cathepsin cysteine protease inhibitors
#542Selective estrogen receptor modulator
#543Antineoplastic ether lipid compounds with modifications at the sn-3 carbon
#544Aminodicarboxylic acid derivatives having pharmaceutical properties
#545Preparation of substituted alkanesulfonates from 2-hydroxyalkanesulfonates
#546Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
#547N-protected/N-substituted-beta-amino hydroxy sulfonates
#548Alkynyl compounds as non nucleoside reverse transcriptase inhibitors
#5493-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
#550Tricyclic steroid hormone nuclear receptor modulators
#551Carboxamidine derivatives and their use in the treatment of vascular diseases
#552Cationic liposomes for gene transfer
#5534-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors
#554Amino-functional chalcones
#555Serotonergic 5HTreceptor compounds for treating ocular and CNS disorders
#556Mercaptoamides as histone deacetylase inhibitors
#557Prodrugs containing novel bio-cleavable linkers
#558Nonaqueous electrolyte and nonaqueous-electrolyte secondary battery
#5593-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
#560Substituted piperazines,(1,4) diazepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine H1 and/or H3 antagonists or histamine H3 reverse antagonists
#561Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
#562Arylpiperazines having activity at the serotonin 1receptor
#563Aryl-substituted piperazine derivatives
#564Naphthaline derivatives as H3 inverse agonists
#565Process for the preparation of 4-(3′-chloro-4′-fluoroanilino) -7-methoxy-6-(3-morpholinopropoxy) quinazoline
#566pH-sensitive cationic lipids, and liposomes and nanocapsules containing the same
#567Arylpiperazines having activity at the serotonin 1A receptor
#568Substituted cyclohexane derivatives
#569Compounds derived from aryl carbamates, preparation thereof and uses of same
#570Aralkyl-alcohol peiperazine derivatives and their uses as antidepressant
#5713- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands
#572Preparation of 4-amino-1-naphthol ethers
#5731,2-di(cyclic)substituted benzene compounds
#574Pharmaceutical compounds
#575Spiro compounds, medicinal compositions containing the same and intermediates of the compounds
#576Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
#577Synthesis and uses of synephrine derivatives
#578β-ketoamide compounds with MCH antagonistic activity
#579Dihydro-dibenzo[b,e]oxepine based selective estrogren receptor modulators, compositions and methods
#580Compounds useful for the treatment of diseases
#581Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
#5823-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
#583Analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders
#584Aminoalkoxy-functional chalcones
#585Non-imidazole aryloxypiperidines
#586Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process
#587N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
#588Serotonergic 5HTreceptor compounds for treating ocular and CNS disorders
#589Compounds that stimulate glucose utilization and methods of use
#590Method for the treatment of allergic conditions
#591Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
#592Method of producing biperiden I
#593Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
#5942,3-Oxidosqualene-lanosterol cyclase inhibitors
#595Enantiomers of 1-(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine
#596Purified racemic lasofoxifene and purified lasofoxifene D-tartrate and a method for effective purification of racemic lasofoxifene
#597Stereoselective alkylation of chiral 2-methyl-4-protected piperazines
#598Alkanol and cycloalkanol-amine derivatives and methods of their use
#599Substituted 10-aryl-11-benzo[]fluorenes and 7-aryl-5, 6-dihydro-benzo[]anthracenes for selective effects on estrogen receptors
#600Compounds that modulate PPAR activity and methods for their preparation